Alveo5 LLC

Alveo Technologies is a molecular diagnostics company specializing in decentralized, point-of-need pathogen detection platforms. The company's flagship be.well platform integrates sample preparation, nucleic acid amplification, and real-time electrical sensing detection into a palm-sized, portable analyzer delivering results in under one hour. Applications span acute respiratory infections (COVID-19, influenza), avian influenza in poultry, plant pathogens in agriculture, and environmental/wastewater surveillance. The platform is cloud-connected, smartphone-guided, and designed for use by non-specialized personnel in field settings. Alveo serves livestock, food & beverage, companion animal, and public health sectors, with partnerships including Royal GD (Netherlands) for veterinary diagnostics and deployment across Egypt for nationwide avian flu surveillance.